Stéphane BargesCEO at LexogenSpeaker
Profile
Stéphane Barges holds a doctorate in Genetics and Molecular Biology from the University of Geneva (Switzerland) and an MBA in International Management from HEC Geneva. He has 20 years of experience in a wide range of management positions in the life science and clinical diagnostics industry. Since 2005, he has worked in various commercial areas and held roles of increasing responsibility at leading companies such as Life Technologies, Bio-Rad, and Tecan, including serving as Vice President in the Molecular Diagnostics division of QIAGEN. In August 2020, Stéphane was appointed CEO of Lexogen, a transcriptomics-focused biotechnology company.